Polyendocrine Metabolic Ovarian Syndrome, or PMOS, is one of the most common hormonal disorders affecting women of reproductive age, impacting roughly 1 in 8 women, or more than 170 million people worldwide. PMOS is the new official name for the condition long known as Polycystic Ovary Syndrome, or PCOS, following a global consensus process published in The Lancet in 2026.
At its core, PMOS is a complex endocrine and metabolic condition involving fluctuating reproductive hormones, insulin resistance, and a wide range of effects on weight, skin, mental health, and fertility, not simply a gynecological issue centered on the ovaries.
What Is PMOS (Polyendocrine Metabolic Ovarian Syndrome)?
PMOS is best understood as a whole-body endocrine disorder rather than a condition confined to the ovaries, even though reproductive symptoms are often what first brings patients to a doctor. Three features tend to appear together in varying combinations: irregular or absent ovulation, elevated levels of androgens, or male-pattern hormones, and, in many but not all patients, the presence of numerous small follicles on the ovaries that can be seen on ultrasound.
No single one of these features defines the condition on its own, which is part of why PMOS looks so different from patient to patient, and why it took a name change to properly reflect its full scope.
The hormonal imbalance at the center of PMOS rarely stays contained to reproductive function. Insulin resistance is present in a large majority of patients, regardless of body weight, and drives many of the condition's downstream effects, from irregular cycles to skin changes to long-term cardiovascular and metabolic risk. Because of this, PMOS is now recognized as sitting at the intersection of endocrinology, metabolism, gynecology, and even dermatology and mental health, which is exactly the multisystem reality the new name was designed to capture.
Understanding PMOS this way, as a condition with effects that extend well beyond the ovaries, is central to how it's diagnosed, monitored, and treated today.
PMOS vs. PCOS: Understanding the Name Change
For decades, the condition was known as PCOS (Polycystic Ovary Syndrome). While the term became widely recognized among patients and healthcare professionals, many experts felt it did not accurately reflect the true nature of the disorder.
The name "polycystic ovary syndrome" places emphasis on ovarian cysts, even though many people diagnosed with the condition do not have ovarian cysts, while ovarian cysts can also occur in people without the syndrome. More importantly, the term focuses attention on the ovaries despite the fact that the condition often affects multiple hormonal and metabolic systems throughout the body.
Why Was PCOS Renamed to PMOS?
To better reflect current scientific understanding, an international group of experts, researchers, and patient advocacy organizations proposed the term PMOS (Polyendocrine Metabolic Ovarian Syndrome). The new name acknowledges that the condition is not solely a reproductive disorder but also involves broader endocrine and metabolic dysfunction.
Each part of the name highlights a key aspect of the condition:
- Polyendocrine: Multiple hormone systems can be affected.
- Metabolic: Insulin resistance and metabolic abnormalities are common features.
- Ovarian: Ovulation and ovarian function remain important components of the syndrome.
The transition from PCOS to PMOS is intended to improve awareness, diagnosis, and understanding of the condition's full health impact. However, because PCOS remains the term most patients recognize, both names are expected to be used together for some time. Importantly, PMOS and PCOS refer to the same condition; the change reflects an evolution in medical terminology rather than the identification of a new disease.
What Causes PMOS?
The exact cause of PMOS isn't fully understood, but it's now recognized as a condition driven by the interaction of hormonal, metabolic, and genetic factors rather than a single ovarian abnormality.
Several mechanisms are believed to contribute to the development of PMOS, including:
- Insulin resistance: One of the most important underlying features of PMOS. When the body's cells don't respond efficiently to insulin, the pancreas produces more of it. Elevated insulin levels can stimulate the ovaries to produce excess androgens.
- Hormonal imbalances: Higher androgen levels can disrupt normal ovulation and contribute to symptoms such as irregular menstrual cycles, acne, and excess hair growth.
- Genetic factors: PMOS tends to run in families, and researchers have identified multiple genes that may influence insulin regulation and reproductive hormone function, although no single gene has been identified as the sole cause.
- Chronic low-grade inflammation: Research suggests that inflammation may both contribute to and result from the hormonal and metabolic disturbances associated with PMOS.
These factors often interact with one another rather than acting independently. For example, insulin resistance can increase androgen production, while elevated androgen levels may further worsen insulin sensitivity, creating a self-reinforcing cycle that affects both metabolic and reproductive health.
Excess weight can amplify insulin resistance and worsen symptoms, but PMOS also affects many people who are not overweight, highlighting that it is a complex endocrine disorder rather than simply a consequence of body weight. Environmental and prenatal factors are also being investigated, with some studies suggesting that exposure to elevated androgen levels before birth may influence the likelihood of developing PMOS later in life.
Symptoms of PMOS
Because PMOS affects multiple body systems, its symptoms can look quite different from one person to the next, and some patients experience a wide array of effects while others notice only one or two, often making the condition harder to recognize without a full evaluation.
- Irregular or absent periods: infrequent, unpredictable, or missing menstrual cycles caused by irregular ovulation.
- Excess androgen effects: symptoms such as excess facial or body hair growth, acne, and thinning hair on the scalp, driven by elevated male-pattern hormones.
- Weight changes and difficulty losing weight: closely tied to underlying insulin resistance.
- Skin changes: including darkened patches of skin, particularly around the neck, armpits, or groin, which often signal insulin resistance.
- Fertility difficulties: irregular or absent ovulation can make conceiving more difficult, making PMOS one of the leading causes of infertility.
- Mood-related symptoms: higher rates of anxiety and depression are commonly reported alongside the condition.
- Sleep disturbances: including a higher likelihood of sleep apnea, independent of body weight.
Because these symptoms overlap with several other hormonal and metabolic conditions, a proper diagnosis relies on a combination of clinical evaluation, blood tests measuring hormone levels, and sometimes pelvic ultrasound, rather than any single symptom or test on its own.
How Is PMOS Diagnosed?
Diagnosing PMOS involves ruling out other conditions that can cause similar symptoms, such as thyroid disorders, elevated prolactin levels, or other causes of excess androgen production, before confirming the diagnosis using established clinical criteria.
Doctors generally look for at least two of the following features:
- Irregular or absent ovulation
- Clinical or laboratory evidence of elevated androgen levels
- The characteristic appearance of the ovaries on ultrasound
Because none of these findings alone confirms PMOS, a thorough medical history and physical examination remain essential parts of the diagnostic process.
A comprehensive evaluation may also include:
- Hormone testing
- Assessment of insulin resistance and blood sugar levels
- Cholesterol and lipid testing
- Thyroid function testing when indicated
- Additional investigations based on individual symptoms
These tests are important because PMOS is associated with long-term metabolic and cardiovascular disease risk that extends beyond reproductive health.
In some patients, doctors may also recommend cardiovascular screening, particularly when obesity, insulin resistance, high blood pressure, or abnormal cholesterol levels are present. Because PMOS can present differently from one person to another, the diagnostic process is typically tailored to each patient's symptoms, risk factors, and overall health profile rather than following a single fixed protocol.
PMOS and Thyroid Disorders: Understanding the Overlap
PMOS shares many symptoms with thyroid disorders, which is why thyroid evaluation is often included in the diagnostic workup. Both conditions can affect menstrual cycles, ovulation, fertility, body weight, energy levels, and mood, sometimes making it difficult to distinguish between them based on symptoms alone.
Thyroid testing helps identify whether symptoms may be related to:
- Hypothyroidism: Often associated with weight gain, fatigue, irregular or heavy periods, fertility difficulties, and slowed metabolism.
- Hyperthyroidism: May cause menstrual irregularities, anxiety, sleep problems, unexplained weight loss, and changes in heart rate.
In some cases, thyroid dysfunction may be responsible for symptoms that initially appear consistent with PMOS. In others, PMOS and thyroid disorders can occur together, adding to the complexity of diagnosis and treatment. Identifying and managing underlying thyroid abnormalities is therefore an important part of developing a comprehensive care plan and addressing the reproductive, metabolic, and hormonal effects associated with PMOS.
Long-Term Health Risks of PMOS
Beyond its immediate symptoms, PMOS is associated with several long-term health risks that make ongoing monitoring an important part of care.
Key concerns include:
- An increased risk of type 2 diabetes due to the insulin resistance commonly seen in PMOS.
- A higher likelihood of developing high blood pressure and unfavorable cholesterol levels.
- An elevated risk of long-term cardiovascular disease, particularly when multiple metabolic risk factors are present.
For this reason, regular metabolic screening is often recommended, even for patients who do not have obvious symptoms of insulin resistance.
Patients who experience infrequent or absent menstrual periods over long periods may also face additional gynecological risks. When ovulation does not occur regularly, the uterine lining can continue to build up without being shed normally, increasing the risk of endometrial hyperplasia and, in some cases, endometrial cancer. Regular gynecological follow-up is therefore an important part of long-term PMOS management.
Although PMOS is distinct from ovarian cancer, persistent pelvic symptoms, ovarian abnormalities detected on imaging, or unexplained changes in reproductive health should always be evaluated by a healthcare professional.
PMOS can also affect emotional well-being and quality of life. Hormonal fluctuations associated with the condition have been linked to higher rates of anxiety, depression, and severe premenstrual symptoms. When mood-related symptoms are significant, evaluation for conditions such as Premenstrual Dysphoric Disorder (PMDD) may be appropriate.
Other reproductive health conditions can further complicate symptom patterns and fertility outcomes. For example, while PMOS is one of the most common causes of ovulatory infertility, fertility challenges may also be influenced by conditions such as endometriosis.
Because PMOS is now recognized as a whole-body endocrine and metabolic condition, long-term care should extend beyond symptom management alone. Ongoing follow-up may include:
- Regular gynecological evaluations
- Fertility assessments when needed
- Monitoring of metabolic and cardiovascular risk factors
- Age-appropriate preventive care
- Routine cervical screening according to current guidelines
This broader approach helps support reproductive health while also addressing the metabolic, hormonal, and cardiovascular effects that can accompany PMOS throughout life.PMOS Treatment Options
There's no single cure for PMOS, and treatment is tailored to each patient's specific symptoms, health goals, and whether fertility is a current priority, which means care usually combines several approaches at once.
Lifestyle and Medical Management
Treatment for PMOS typically combines lifestyle strategies with medical therapies tailored to each patient's symptoms and health goals. Common approaches include:
- Lifestyle changes: Regular physical activity and a balanced diet can improve insulin sensitivity, support hormonal balance, and help restore more regular ovulation.
- Hormonal treatments: Hormonal birth control may help regulate menstrual cycles and reduce symptoms such as acne and excess hair growth.
- Insulin-sensitizing medications: Drugs such as metformin are often used to address insulin resistance, a key feature of PMOS.
- Ongoing monitoring: Regular assessment of blood sugar, cholesterol, and blood pressure may be recommended due to the condition's long-term metabolic and cardiovascular risks.
Because PMOS affects multiple body systems, treatment is often most effective when both its hormonal and metabolic aspects are addressed together.
Fertility-Focused Treatment
For patients trying to conceive, treatment shifts toward inducing regular ovulation, typically starting with oral medications designed to stimulate the ovaries. When oral medication alone isn't effective, injectable fertility medications or in vitro fertilization may be considered, often alongside the same lifestyle and insulin-management strategies used more broadly, since improving metabolic health frequently improves fertility outcomes as well.
Because irregular ovulation is often the central obstacle to conception in PMOS, many patients see meaningful improvement once an effective combination of treatments is found, even after previous cycles without success.
Surgical Options
In select cases where medication hasn't successfully induced ovulation, a minimally invasive procedure called laparoscopic ovarian drilling may be used, in which small areas of ovarian tissue are treated to help restore more regular ovulation. This approach is generally considered only after other fertility treatments have been tried, and is used far less frequently than lifestyle and medical management, though it can be an effective option for patients who haven't responded to medication alone.
Advanced Gynecology, Endocrinology, Fertility, and Metabolic Care at Medical Park
Medical Park's Gynecology and Endocrinology specialists provide comprehensive, individualized care for PMOS in Turkey, from initial diagnosis through long-term management of its reproductive, metabolic, and hormonal effects. Whether a patient's primary concern is irregular menstrual cycles, fertility challenges, weight management, acne, excess hair growth, or the broader metabolic and cardiovascular risks associated with the condition, Medical Park's multidisciplinary teams develop personalized treatment plans based on each patient's symptoms, health goals, and stage of life.
The diagnostic process may include hormonal evaluation, metabolic assessment, pelvic ultrasound, and screening for conditions commonly associated with PMOS, such as insulin resistance, prediabetes, type 2 diabetes, and dyslipidemia. This comprehensive approach helps identify both the reproductive manifestations of PMOS and the underlying metabolic factors that can influence long-term health outcomes.
Treatment options may include lifestyle and nutritional counseling, medications to regulate menstrual cycles and hormone levels, insulin-sensitizing therapies, and fertility-focused treatments when pregnancy is desired. For patients experiencing infertility related to ovulatory dysfunction, Medical Park's reproductive medicine and IVF specialists provide advanced fertility evaluation and assisted reproductive treatment options when appropriate.
As a leading provider of gynecology and endocrinology care in Turkey, Medical Park offers an integrated approach that brings together specialists from multiple disciplines to address the full spectrum of PMOS-related concerns. By combining expertise in women's health, hormone disorders, metabolic medicine, fertility treatment, and preventive care, Medical Park helps patients manage symptoms, reduce long-term health risks, and improve their overall quality of life through coordinated, evidence-based care.